Leptin In Malign Pleural Efusions: May Be A New Marker?

Objective: The pleural effusions may be caused by malignant or benign diseases. In this study, it was aimed to determine the serum and pleural leptin levels in non-malignant and malignant pleural effusions.Methods: Patients with non-malignant (n=20) and malignant pleural effusions (n=20), and health...

Full description

Saved in:
Bibliographic Details
Main Authors: Serap Duru, Zeynep Sönmez, Yasemin Saygıdeger, Alper Dilli, Günnur Dikmen, Özlem Sever, Sadık Ardıç
Format: Article
Language:English
Published: Galenos Publishing House 2011-12-01
Series:Ankara Üniversitesi Tıp Fakültesi Mecmuas
Subjects:
Online Access: http://ankaratipfakultesimecmuasi.net/archives/archive-detail/article-preview/leptin-n-malign-pleural-efusions-may-be-a-new-mark/18582
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849396342283042816
author Serap Duru
Zeynep Sönmez
Yasemin Saygıdeger
Alper Dilli
Günnur Dikmen
Özlem Sever
Sadık Ardıç
author_facet Serap Duru
Zeynep Sönmez
Yasemin Saygıdeger
Alper Dilli
Günnur Dikmen
Özlem Sever
Sadık Ardıç
author_sort Serap Duru
collection DOAJ
description Objective: The pleural effusions may be caused by malignant or benign diseases. In this study, it was aimed to determine the serum and pleural leptin levels in non-malignant and malignant pleural effusions.Methods: Patients with non-malignant (n=20) and malignant pleural effusions (n=20), and healthy control group (n=20) were included in this cross-sectional study. The age and body mass index (BMI) were comparative between study groups. The serum leptin levels in all subjects and pleural effu-sions leptin level in patients with pleural effusion were determined. Leptin levels were compared in terms of study groups and gender of subjects.Results: The leptin levels in serum and pleural effusions in group with malignant pleural effusion were significantly higher than both the non-malignant effusion and control groups (p<0.001). While there was no statistically significant difference between male and female patients in terms of pleural effusions leptin levels (p=0.097), serum leptin level of the female patients was significantly higher than the male patients (p<0.001).Conclusion: Increased serum and pleural effusions leptin levels in malignant pleural effusions shows that leptin is a useful new marker.
format Article
id doaj-art-b48030f3d3ad4f89806c0ee1b78af443
institution Kabale University
issn 1307-5608
1307-5608
language English
publishDate 2011-12-01
publisher Galenos Publishing House
record_format Article
series Ankara Üniversitesi Tıp Fakültesi Mecmuas
spelling doaj-art-b48030f3d3ad4f89806c0ee1b78af4432025-08-20T03:39:22ZengGalenos Publishing HouseAnkara Üniversitesi Tıp Fakültesi Mecmuas1307-56081307-56082011-12-0164312713110.1501/Tipfak_000000079613049054Leptin In Malign Pleural Efusions: May Be A New Marker?Serap Duru0Zeynep Sönmez1Yasemin Saygıdeger2Alper Dilli3Günnur Dikmen4Özlem Sever5Sadık Ardıç6 Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Göğüs Hastalıkları Kliniği, Ankara Afyon Göğüs Hastalıkları Hastanesi, Afyon Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Göğüs Hastalıkları Kliniği, Ankara Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Radyoloji Kliniği, Ankara Hacettepe Üniversitesi Tıp Fakültesi, Biyokimya Anabilim Dalı, Ankara Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Göğüs Hastalıkları Kliniği, Ankara Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Göğüs Hastalıkları Kliniği, Ankara Objective: The pleural effusions may be caused by malignant or benign diseases. In this study, it was aimed to determine the serum and pleural leptin levels in non-malignant and malignant pleural effusions.Methods: Patients with non-malignant (n=20) and malignant pleural effusions (n=20), and healthy control group (n=20) were included in this cross-sectional study. The age and body mass index (BMI) were comparative between study groups. The serum leptin levels in all subjects and pleural effu-sions leptin level in patients with pleural effusion were determined. Leptin levels were compared in terms of study groups and gender of subjects.Results: The leptin levels in serum and pleural effusions in group with malignant pleural effusion were significantly higher than both the non-malignant effusion and control groups (p<0.001). While there was no statistically significant difference between male and female patients in terms of pleural effusions leptin levels (p=0.097), serum leptin level of the female patients was significantly higher than the male patients (p<0.001).Conclusion: Increased serum and pleural effusions leptin levels in malignant pleural effusions shows that leptin is a useful new marker. http://ankaratipfakultesimecmuasi.net/archives/archive-detail/article-preview/leptin-n-malign-pleural-efusions-may-be-a-new-mark/18582 Leptinmalignancypleural effusion
spellingShingle Serap Duru
Zeynep Sönmez
Yasemin Saygıdeger
Alper Dilli
Günnur Dikmen
Özlem Sever
Sadık Ardıç
Leptin In Malign Pleural Efusions: May Be A New Marker?
Ankara Üniversitesi Tıp Fakültesi Mecmuas
Leptin
malignancy
pleural effusion
title Leptin In Malign Pleural Efusions: May Be A New Marker?
title_full Leptin In Malign Pleural Efusions: May Be A New Marker?
title_fullStr Leptin In Malign Pleural Efusions: May Be A New Marker?
title_full_unstemmed Leptin In Malign Pleural Efusions: May Be A New Marker?
title_short Leptin In Malign Pleural Efusions: May Be A New Marker?
title_sort leptin in malign pleural efusions may be a new marker
topic Leptin
malignancy
pleural effusion
url http://ankaratipfakultesimecmuasi.net/archives/archive-detail/article-preview/leptin-n-malign-pleural-efusions-may-be-a-new-mark/18582
work_keys_str_mv AT serapduru leptininmalignpleuralefusionsmaybeanewmarker
AT zeynepsonmez leptininmalignpleuralefusionsmaybeanewmarker
AT yaseminsaygıdeger leptininmalignpleuralefusionsmaybeanewmarker
AT alperdilli leptininmalignpleuralefusionsmaybeanewmarker
AT gunnurdikmen leptininmalignpleuralefusionsmaybeanewmarker
AT ozlemsever leptininmalignpleuralefusionsmaybeanewmarker
AT sadıkardıc leptininmalignpleuralefusionsmaybeanewmarker